{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:F4JCU0",
      "entity_text" : "SUA",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07664",
      "entity_text" : "xanthine oxidase inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Approved SUA lowering treatments include xanthine oxidase inhibitors, such as allopurinol, which has been widely used for the treatment of gout since the 1960s [XREF_BIBR - XREF_BIBR], in combination with low-dose, daily colchicine for the prophylaxis of flares [XREF_BIBR].",
  "reading_complete" : "2020-07-28T17:22:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:15:21Z",
  "trigger" : "lowering",
  "evidence" : [ "SUA-lowering treatments include xanthine oxidase inhibitors" ],
  "pmc_id" : "6858416",
  "score" : 0
}